Genomic characterization of Haemophilus influenzae: a focus on the capsule locus.


Journal

BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258

Informations de publication

Date de publication:
12 Oct 2019
Historique:
received: 15 03 2019
accepted: 26 09 2019
entrez: 14 10 2019
pubmed: 14 10 2019
medline: 26 2 2020
Statut: epublish

Résumé

Haemophilus influenzae (Hi) can cause invasive diseases such as meningitis, pneumonia, or sepsis. Typeable Hi includes six serotypes (a through f), each expressing a unique capsular polysaccharide. The capsule, encoded by the genes within the capsule locus, is a major virulence factor of typeable Hi. Non-typeable (NTHi) does not express capsule and is associated with invasive and non-invasive diseases. A total of 395 typeable and 293 NTHi isolates were characterized by whole genome sequencing (WGS). Phylogenetic analysis and multilocus sequence typing were used to characterize the overall genetic diversity. Pair-wise comparisons were used to evaluate the capsule loci. A WGS serotyping method was developed to predict the Hi serotype. WGS serotyping results were compared to slide agglutination (SAST) or real-time PCR (rt-PCR) serotyping. Isolates of each Hi serotype clustered into one or two subclades, with each subclade being associated with a distinct sequence type (ST). NTHi isolates were genetically diverse, with seven subclades and 125 STs being detected. Regions I and III of the capsule locus were conserved among the six serotypes (≥82% nucleotide identity). In contrast, genes in Region II were less conserved, with only six gene pairs from all serotypes showing ≥56% nucleotide identity. The WGS serotyping method was 99.9% concordant with SAST and 100% concordant with rt-PCR in determining the Hi serotype. Genomic analysis revealed a higher degree of genetic diversity among NTHi compared to typeable Hi. The WGS serotyping method accurately predicted the Hi capsule type and can serve as an alternative method for Hi serotyping.

Sections du résumé

BACKGROUND BACKGROUND
Haemophilus influenzae (Hi) can cause invasive diseases such as meningitis, pneumonia, or sepsis. Typeable Hi includes six serotypes (a through f), each expressing a unique capsular polysaccharide. The capsule, encoded by the genes within the capsule locus, is a major virulence factor of typeable Hi. Non-typeable (NTHi) does not express capsule and is associated with invasive and non-invasive diseases.
METHODS METHODS
A total of 395 typeable and 293 NTHi isolates were characterized by whole genome sequencing (WGS). Phylogenetic analysis and multilocus sequence typing were used to characterize the overall genetic diversity. Pair-wise comparisons were used to evaluate the capsule loci. A WGS serotyping method was developed to predict the Hi serotype. WGS serotyping results were compared to slide agglutination (SAST) or real-time PCR (rt-PCR) serotyping.
RESULTS RESULTS
Isolates of each Hi serotype clustered into one or two subclades, with each subclade being associated with a distinct sequence type (ST). NTHi isolates were genetically diverse, with seven subclades and 125 STs being detected. Regions I and III of the capsule locus were conserved among the six serotypes (≥82% nucleotide identity). In contrast, genes in Region II were less conserved, with only six gene pairs from all serotypes showing ≥56% nucleotide identity. The WGS serotyping method was 99.9% concordant with SAST and 100% concordant with rt-PCR in determining the Hi serotype.
CONCLUSIONS CONCLUSIONS
Genomic analysis revealed a higher degree of genetic diversity among NTHi compared to typeable Hi. The WGS serotyping method accurately predicted the Hi capsule type and can serve as an alternative method for Hi serotyping.

Identifiants

pubmed: 31606037
doi: 10.1186/s12864-019-6145-8
pii: 10.1186/s12864-019-6145-8
pmc: PMC6790013
doi:

Substances chimiques

Polysaccharides, Bacterial 0
Virulence Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

733

Références

Clin Infect Dis. 2011 Dec;53(12):1230-6
pubmed: 22080119
Int J Med Microbiol. 2011 Feb;301(2):176-9
pubmed: 20940106
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Infect Genet Evol. 2019 Jan;67:126-135
pubmed: 30391557
Bioinformatics. 2009 Jun 1;25(11):1422-3
pubmed: 19304878
J Bacteriol. 2006 Jun;188(11):3870-7
pubmed: 16707679
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Mol Microbiol. 1995 Jan;15(1):107-18
pubmed: 7752885
J Clin Microbiol. 2007 Jul;45(7):2305-8
pubmed: 17507524
Curr Biol. 1996 Mar 1;6(3):279-91
pubmed: 8805245
J Clin Microbiol. 1994 Oct;32(10):2382-6
pubmed: 7814470
J Clin Microbiol. 2019 May 24;57(6):null
pubmed: 30944197
Bioinformatics. 2014 May 1;30(9):1236-40
pubmed: 24451626
Mol Biol Evol. 2006 Feb;23(2):254-67
pubmed: 16221896
J Bacteriol. 2005 Jul;187(13):4627-36
pubmed: 15968074
Microbiology. 2012 Dec;158(Pt 12):2958-64
pubmed: 23038806
J Bacteriol. 1989 Jun;171(6):3343-7
pubmed: 2785986
PLoS One. 2016 Feb 01;11(2):e0147765
pubmed: 26829233
Infect Genet Evol. 2013 Mar;14:125-36
pubmed: 23266487
J Bacteriol. 1999 Apr;181(7):2001-7
pubmed: 10094675
Epidemiol Infect. 2017 Jun;145(8):1727-1736
pubmed: 28260537
J Clin Microbiol. 2003 Jan;41(1):393-6
pubmed: 12517878
Open Forum Infect Dis. 2014 Jul 03;1(2):ofu044
pubmed: 25734116
J Clin Microbiol. 2012 Apr;50(4):1422-4
pubmed: 22301020
Mol Cell Probes. 2013 Apr;27(2):86-9
pubmed: 23195602
BMC Genomics. 2011 Apr 13;12:187
pubmed: 21489287
Mol Microbiol. 1990 Nov;4(11):1853-62
pubmed: 2082145
Emerg Infect Dis. 2016 Oct;22(10):1762-1768
pubmed: 27649262
Res Microbiol. 2011 Jun;162(5):483-7
pubmed: 21513796
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Infect Immun. 2003 Dec;71(12):7202-7
pubmed: 14638817
Clin Infect Dis. 2018 Aug 31;67(6):881-889
pubmed: 29509834
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5439-44
pubmed: 24706866
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Int J Med Microbiol. 2011 Apr;301(4):303-9
pubmed: 21276750
Science. 1995 Jul 28;269(5223):496-512
pubmed: 7542800
Diagn Microbiol Infect Dis. 2000 May;37(1):1-4
pubmed: 10794932
Bioinformatics. 2015 Sep 1;31(17):2877-8
pubmed: 25913206
J Clin Microbiol. 2003 Apr;41(4):1623-36
pubmed: 12682154
Cell. 1988 May 6;53(3):347-56
pubmed: 3284653
Clin Microbiol Infect. 2016 Jan;22(1):63.e7-63.e8
pubmed: 26454058
J Bacteriol. 2008 Feb;190(4):1473-83
pubmed: 18065541
Genome Biol. 2007;8(6):R103
pubmed: 17550610
J Clin Microbiol. 2010 Apr;48(4):1404-7
pubmed: 20107095
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147

Auteurs

Caelin C Potts (CC)

Bacterial Meningitis Laboratory, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H17-2, Atlanta, GA, 30329, USA.

Nadav Topaz (N)

CDC Foundation, Atlanta, GA, USA.

Lorraine D Rodriguez-Rivera (LD)

IHRC Inc., Atlanta, GA, USA.

Fang Hu (F)

IHRC Inc., Atlanta, GA, USA.

How-Yi Chang (HY)

IHRC Inc., Atlanta, GA, USA.

Melissa J Whaley (MJ)

Bacterial Meningitis Laboratory, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H17-2, Atlanta, GA, 30329, USA.

Susanna Schmink (S)

Bacterial Meningitis Laboratory, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H17-2, Atlanta, GA, 30329, USA.

Adam C Retchless (AC)

Bacterial Meningitis Laboratory, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H17-2, Atlanta, GA, 30329, USA.

Alexander Chen (A)

Bacterial Meningitis Laboratory, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H17-2, Atlanta, GA, 30329, USA.

Edward Ramos (E)

CSRA, Inc., Atlanta, GA, USA.

Gregory H Doho (GH)

CSRA, Inc., Atlanta, GA, USA.

Xin Wang (X)

Bacterial Meningitis Laboratory, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H17-2, Atlanta, GA, 30329, USA. gqe8@cdc.gov.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH